Veterinary Pharmaceuticals Global Market Opportunities And Strategies To 2033

Veterinary Pharmaceuticals Market 2024 – By Type (Veterinary Vaccines, Veterinary Antibiotics, Veterinary Parasiticides, Other Veterinary Pharmaceuticals), By Type Of Animal (Livestock Animals, Companion Animals), By Type Of Vaccine (Inactivated Vaccines, Attenuated Vaccines, Recombinant Vaccines, Other Vaccines), By Route Of Administration (Oral, Parenteral, Topical, Other Routes Of Administration), By End-User (Veterinary Hospitals, Veterinary Clinics, Pharmacies And Drug Stores), And By Region, Opportunities And Strategies – Global Forecast To 2033

Veterinary Pharmaceuticals Global Market Opportunities And Strategies To 2033

Starting Price : $5000.00 | Pages : 351 | Published : July 2024 | | Format : pdf

Need assistance or more information before the purchase?

Enquire Before Buying
Veterinary Pharmaceuticals Global Market Opportunities And Strategies To 2032

Proud Members Of

checkslacipN checkaoirsN checkscipN

Veterinary Pharmaceuticals Market Definition

Veterinary pharmaceuticals or veterinary drugs are drugs that are intended for use in animals in the case of disease or illness. These products achieve their effect through pharmacological actions in the animal body.

The veterinary pharmaceuticals market consists of sales of veterinary pharmaceuticals by entities (organizations, sole traders and partnerships) that manufacture veterinary pharmaceuticals (or drugs) used to sedate, treat animal diseases and/or to improve animals’ performance and health. The veterinary pharmaceuticals industry includes establishments that manufacture veterinary pharmaceuticals such as veterinary vaccines, veterinary antibiotics and other veterinary pharmaceuticals.

Veterinary Pharmaceuticals Market Size

The global veterinary pharmaceuticals market reached a value of nearly $31,099.8 million in 2023, having grown at a compound annual growth rate (CAGR) of 6.0% since 2018. The market is expected to grow from $31,099.8 million in 2023 to $43,910.7 million in 2028 at a rate of 7.1%. The market is then expected to grow at a CAGR of 7.9% from 2028 and reach $64,188.6 million in 2033.    

Growth in the historic period resulted from the increased pet population, increased overall spending by individuals on pets, growing penetration of e-commerce platforms promoting online pharmacies and emerging markets growth. Factors that negatively affected growth in the historic period include coronavirus (COVID-19) outbreak, a lack of awareness, inappropriate use of medicines and high cost of animal treatment.

Going forward, the increasing pet ownership, rising disposable income, increasing urbanization, increasing penetration of pet insurance and growing government support will drive the market. Factors that could hinder the growth of the veterinary pharmaceuticals market in the future include a shortage of veterinarians, lack of infrastructure for providing emergency veterinary services, stringent rules and regulations in animal testing and restrictions, high cost associated with animal healthcare drugs in low-middle income countries and increasing influx of counterfeit drugs.

Veterinary Pharmaceuticals Market Drivers

The key drivers of the veterinary pharmaceuticals market include:

Increasing Pet Ownership

Increasing pet ownership will drive the growth of the veterinary pharmaceuticals market during the forecast period. For instance, For example, in April 2023, according to the American Pet Products Association, a US-based not-for-profit industry association, millennials and Generation Z made up nearly half the pet owning population in the United States in 2022. This trend is significant due to millennials and Generation Z are known for their strong attachment to their pets and their willingness to spend on pet care products and services.  Further, China’s domestic cat population is estimated to grow from 95 million to 101 million with a CAGR of 6% between 2021 and 2025, while the domestic dog population is expected to grow from 98 million to 100 million with a CAGR of 2.5% in the same period.  Therefore, the increasing pet ownership is expected to drive the veterinary pharmaceuticals market going forward.

Veterinary Pharmaceuticals Market Restraints

The key restraints on the veterinary pharmaceuticals market include:

Shortage Of Veterinarians

A shortage of veterinarians is expected to restrain the growth of the veterinary pharmaceuticals market going forward. The veterinary shortage has put a significant pressure on professionals. In the long term, changes in pay, work-life balance and client expectations is expected to drive dissatisfaction. In the short term, the COVID-19 pandemic has increased practice inefficiency and therefore backlogs, exacerbating shortages.  For instance, in March 2022, according to Mars Veterinary Health, a US-based provider of veterinary care and employer of veterinary professionals, with an average of 2,500-2,600 graduates becoming veterinarians each year, there is an estimated 15,000 veterinarian shortage for US animals by 2030. According to Banfield Pet Hospital, a US-based private company, a potential shortage of this size will leave 75 million pets without veterinary care by 2030.  Therefore, the shortage of veterinarians will limit the growth of the veterinary pharmaceuticals market.

Veterinary Pharmaceuticals Market Trends

Major trends shaping the veterinary pharmaceuticals market include:

Increased Focus On Stem Cell Therapy To Treat Animals

Stem cell therapy is being increasingly adopted by veterinarians to treat orthopedic conditions such as osteoarthritis, ligament injuries and tendons in high commercial value species, such as racehorses. Stem cell therapy helps to restore motion and stimulate the regeneration of tendon, ligament and joint tissues by isolating adult stem cells from an animals’ fat tissue and re-introducing these cells to reduce pain and inflammation. Some of the companies offering stem cell therapy in the USA include VetStem and MediVet. For instance, in April 2022, Boehringer Ingelheim, a German pharmaceutical company, launched RenuTend, a stem cell therapy for horses. It improves healing of tendon and suspensory ligament injuries. It is administered intralesionally, targeting fiber alignment and reducing scar tissue formation, enhancing the quality of healing.

Application Of Nanotechnology In Veterinary Medicines To Tackle Antibiotic Resistance

To tackle antibiotic resistance, nanotechnology is being considered in the veterinary pharmaceuticals market as a substitute for veterinary antibiotics. Nanotechnology is the study of the control of matter on an atomic and molecular scale.  In the veterinary pharmaceutical industry, nanotechnology is used to improve diagnosis, treatment, animal growth promotion and production. Silver nanoparticles are mainly used as alternative antimicrobial agents to reduce the use of antibiotics and improve the detection of pathogenic bacteria. They are also used as drug delivery agents for new drugs and vaccine candidates to improve their characteristics and performance and to reduce drug resistance in animal organisms.  For example, companies such as SkyePharma, IDEXX and Probiomed are developing nanoparticle veterinary applications for drug discovery, disease detection and others.

Opportunities And Recommendations In The Veterinary Pharmaceuticals Market

Opportunities – The top opportunities in the veterinary pharmaceuticals market segmented by type will arise in the veterinary parasiticides segment, which will gain $4,735.4 million of global annual sales by 2028. The top opportunities in the veterinary pharmaceuticals market segmented by type of animal will arise in the companion animals segment, which will gain $8,586.7 million of global annual sales by 2028. The top opportunities in the veterinary pharmaceuticals market segmented by type of vaccine will arise in the attenuated vaccines segment, which will gain $5,139.3 million of global annual sales by 2028. The top opportunities in the veterinary pharmaceuticals market segmented by route of administration will arise in the parenteral segment, which will gain $5,826.3 million of global annual sales by 2028. The top opportunities in the veterinary pharmaceuticals market segmented by end-user will arise in the veterinary hospitals segment, which will gain $5,675.6 million of global annual sales by 2028. The veterinary pharmaceuticals market size will gain the most in the USA at $2,008.7 million.

Recommendations- To take advantage of the opportunities, The Business Research Company recommends the veterinary pharmaceuticals companies to focus on adopting stem cell therapy for orthopedic conditions in high-value species, focus on leveraging nanotechnology for veterinary pharmaceuticals, focus on developing chewable tablets for enhanced treatment compliance, focus on integrating telemedicine platforms for enhanced veterinary care, focus on advancing vaccine development for animal health, focus on developing combination parasiticides for enhanced parasite control, focus on veterinary antibiotics segment, focus on companion animals segment, focus on recombinant vaccines segment, expand in emerging markets, focus on strategic partnerships for market expansion, focus on diversifying distribution channels, provide competitively priced offerings, focus on educational content marketing, participate in trade shows and events, continue to use B2B promotions and focus on building strong partnerships with veterinary professionals.

Veterinary Pharmaceuticals Market Segmentation

The veterinary pharmaceuticals market is segmented by type, by type of animal, by type of vaccine, by route of administration and by end-user.

By Type –
The veterinary pharmaceuticals market is segmented by type into:
    • a) Veterinary Vaccines
    • b) Veterinary Antibiotics
    • c) Veterinary Parasiticides
    • d) Other Veterinary Pharmaceuticals
The veterinary parasiticides market was the largest segment of the veterinary pharmaceuticals market segmented by type, accounting for 42.6% or $13,255.0 million of the total in 2023. Going forward, the veterinary antibiotics segment is expected to be the fastest growing segment in the veterinary pharmaceuticals market segmented by type, at a CAGR of 9.9% during 2023-2028.

By Type Of Animal –
The veterinary pharmaceuticals market is segmented by type of animal into:
    • a) Livestock Animals
    • b) Companion Animals
The companion animals market was the largest segment of the veterinary pharmaceuticals market segmented by type of animal, accounting for 51.0% or $15,865.5 million of the total in 2023. Going forward, the companion animals segment is expected to be the fastest growing segment in the veterinary pharmaceuticals market segmented by type of animal, at a CAGR of 9.0% during 2023-2028.

By Type Of Vaccine –
The veterinary pharmaceuticals market is segmented by type of vaccine into:
    • a) Inactivated Vaccines
    • b) Attenuated Vaccines
    • c) Recombinant Vaccines
    • d) Other Vaccines
The attenuated vaccines market was the largest segment of the veterinary pharmaceuticals market segmented by type of vaccine, accounting for 39.1% or $12,145.0 million of the total in 2023. Going forward, the recombinant vaccines segment is expected to be the fastest growing segment in the veterinary pharmaceuticals market segmented by type of vaccine, at a CAGR of 7.4% during 2023-2028.

By Route Of Administration –
The veterinary pharmaceuticals market is segmented by route of administration into:
    • a) Oral
    • b) Parenteral
    • c) Topical
    • d) Other Routes Of Administration
The parenteral market was the largest segment of the veterinary pharmaceuticals market segmented by route of administration, accounting for 45.6% or $14,189.7 million of the total in 2023. Going forward, the oral segment is expected to be the fastest growing segment in the veterinary pharmaceuticals market segmented by route of administration, at a CAGR of 7.4% during 2023-2028.

By End-User –
The veterinary pharmaceuticals market is segmented by end-user into:
    • a) Veterinary Hospitals
    • b) Veterinary Clinics
    • c) Pharmacies
    • d) Drug Stores
The veterinary hospitals market was the largest segment of the veterinary pharmaceuticals market segmented by end-user, accounting for 49.7% or $15,441.7 million of the total in 2023. Going forward, the veterinary clinics segment is expected to be the fastest growing segment in the veterinary pharmaceuticals market segmented by end-user, at a CAGR of 9.0% during 2023-2028.

By Geography - The veterinary pharmaceuticals market is segmented by geography into:
      o Asia Pacific
      • • China
      • • India
      • • Japan
      • • Australia
      • • Indonesia
      • • South Korea
      o North America
      • • USA
      • • Canada
      • • Ontario
      o South America
      • • Brazil
      o Western Europe
      • • France
      • • Germany
      • • UK
      • • Italy
      • • Spain
      o Eastern Europe
      • • Russia
      o Middle East
      o Africa
North America was the largest region in the veterinary pharmaceuticals market, accounting for 46.4% or $14,420.3 million of the total in 2023. It was followed by Asia-Pacific, Western Europe and then the other regions. Going forward, the fastest-growing regions in the veterinary pharmaceuticals market will be South America and the Middle East, where growth will be at CAGRs of 20.3% and 18.9% respectively. These will be followed by Africa and Eastern Europe, where the markets are expected to grow at CAGRs of 12.4% and 7.7% respectively.

Veterinary Pharmaceuticals Market Competitive Landscape

Major Competitors are:

  • Merck & Co., Inc.
  • Boehringer Ingelheim International GmbH
  • Elanco Animal Health Incorporated
  • Zoetis Inc
  • Ceva Sante Animale
  • Other Competitors Include:

  • Virbac SA
  • Dechra Pharmaceuticals PLC
  • Vetoquinol S.A.
  • Evonik Industries AG
  • Zydus Animal Health
  • Milma
  • Immunologix India Pvt Ltd (IGY)
  • DCC Animal Hospital
  • Sun Pharmaceuticals Industries Limited
  • Vivaldis Health and Foods Pvt Ltd
  • Zenex Animal Health India Private Limited (Zenex)
  • New Ruipeng Group (NRP Group)
  • National Meditek
  • Fartovet Industry Limited
  • Hebei Chengshengtang Animal Pharmaceutical
  • Shijiazhuang Fengqiang Animal Pharmaceutical Co Ltd
  • Vvaan Lifesciences Private Limited
  • Century Pharmaceuticals Limited
  • Cargill India Pvt Ltd
  • Jurox Pty Ltd
  • IDT Biologika GmbH
  • Scil Animal Care
  • Heska Corporation
  • Heiland GmbH
  • Global Stem Cell Technology
  • Inovet
  • Ceva Santé Animale
  • Bayer
  • Veteq
  • Nimrod Veterinary Products Ltd
  • Bimeda
  • Vetoquinol SA
  • Orion Animal Health
  • Laboratorios Calier SA
  • Petmedix
  • Eco Animal Health
  • Teknofarma
  • Farmavet
  • Candioli Pharma
  • Suanfarma
  • Marino Ibericamed
  • MPA veterinary
  • Lamons Laboratories SA
  • Swetrade Pharmaceuticals AB
  • Animalcare
  • AVZ LTD
  • Nasr Pharmaceutical Company
  • VIC Group
  • VET-AGRO Sp. z o. o
  • CANPOLAND SA
  • Cymedica
  • NITA-FARM
  • Apicenna LLC
  • Delos Medica
  • Provet Group
  • VitOMEK LCC
  • Bioveta AS
  • Veterinarski Zavod Subotica
  • Biowet Pulawy sp. z o.o
  • PharmaGal s.r.o
  • Bond Vet
  • VetStrategy
  • Diamond Animal Health
  • Phibro Animal Health Corporation
  • VetNova
  • Piedmont Animal Health
  • Modern Animal
  • Merck & Co Inc
  • Trifecta Pharmaceuticals USA LLC
  • Alberta Veterinary Laboratories Ltd
  • Virbac
  • Veterinary Purchasing Co Ltd
  • Maure
  • Ouro Fino Saúde Animal Participações
  • Peru Animal Hospital
  • Miami County Veterinary Clinic
  • Cindy Fouts
  • Vetanco
  • Chemo Argentina
  • Brouwer
  • Agrovet Market Animal Health
  • Lemavet
  • Primo Veterinary Medicines Trading LLC
  • Eurovets Veterinary Suppliers
  • Physio Evolution
  • Herzliya Veterinary Hospital
  • Oron Veterinary Center
  • Saudi Pharmaceutical Industries (SPI)
  • DBK Pharma S.A.E
  • MSD Animal Health
  • Afrivet
  • Dawa Limited
  • Aesthetics Limited
  • Neimeth International Pharmaceuticals
  • Osy-Adamu Pharmaceutical Co
  • M S J Afro Agro Pharmacy
  • Global Vet (U) Ltd
  • Multivet Ghana Ltd
    1. Table Of Contents

      1 Executive Summary

      1.1 Veterinary Pharmaceuticals – Market Attractiveness And Macro economic Landscape

      2 Table Of Contents

      3 List Of Tables

      4 List Of Figures

      5 Report Structure

      6 Market Characteristics

      6.1 General Market Definition

      6.2 Summary

      6.3 Veterinary Pharmaceuticals Market Definition And Segmentations

      6.4 Market Segmentation By Type

      6.4.1 Veterinary Vaccines

      6.4.2 Veterinary Antibiotics

      6.4.3 Veterinary Parasiticides

      6.4.4 Other Veterinary Pharmaceuticals

      6.5 Market Segmentation By Type Of Animal

      6.5.1 Livestock Animals

      6.5.2 Companion Animals

      6.6 Market Segmentation By Type Of Vaccine

      6.6.1 Inactivated Vaccines

      6.6.2 Attenuated Vaccines

      6.6.3 Recombinant Vaccines

      6.6.4 Other Vaccines

      6.7 Market Segmentation By Route Of Administration

      6.7.1 Oral

      6.7.2 Parenteral

      6.7.3 Topical

      6.7.4 Other Routes Of Administration

      6.8 Market Segmentation By End-User

      6.8.1 Veterinary Hospitals

      6.8.2 Veterinary Clinics

      6.8.3 Pharmacies And Drug Stores

      7 Major Market Trends

      7.1 Increased Focus On Stem Cell Therapy To Treat Animals

      7.2 Application Of Nanotechnology In Veterinary Medicines To Tackle Antibiotic Resistance

      7.3 Development Of Chewable Tablets To Improve Convenience In Animals

      7.4 Use Of Telemedicine Platforms To Improve Access To Care

      7.5 Development Of Advanced Vaccines To Reduce Disease Burden In Animals

      7.6 Development Of Super-Combo Parasiticides To Help Control Parasites

      7.7 Use Of Subunit And Virus-Like Particle (VLP)-Based Vaccines

      7.8 Strategic Partnerships And Collaborations Among Market Players

      8 Veterinary Pharmaceuticals Market - Macro Economic Scenario

      8.1 COVID-19 Impact On The Veterinary Pharmaceuticals Market

      8.2 Impact Of The War In Ukraine On The Veterinary Pharmaceuticals Market

      8.3 Impact Of High Inflation On The Veterinary Pharmaceuticals Market

      9 Global Market Size and Growth

      9.1 Market Size

      9.2 Historic Market Growth, 2018 – 2023, Value ($ Million)

      9.2.1 Market Drivers 2018-2023

      9.2.2 Market Restraints 2018 – 2023

      9.3 Forecast Market Growth, 2023 – 2028, 2033F Value ($ Million)

      9.3.1 Market Drivers 2023 – 2028

      9.3.2 Market Restraints 2023 – 2028

      10 Global Veterinary Pharmaceuticals Market Segmentation

      10.1 Global Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      10.2 Global Veterinary Pharmaceuticals Market, Segmentation By Type Of Animal, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      10.3 Global Veterinary Pharmaceuticals Market, Segmentation By Type Of Vaccine, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      10.4 Global Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      10.5 Global Veterinary Pharmaceuticals Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      11 Veterinary Pharmaceuticals Market, Regional and Country Analysis

      11.1 Global Veterinary Pharmaceuticals Market, By Region, Historic and Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      11.2 Global Veterinary Pharmaceuticals Market, By Country, Historic and Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12 Asia-Pacific Market

      12.1 Summary

      12.1.1 Market Overview

      12.1.2 Region Information

      12.1.3 Market Information

      12.1.4 Background Information

      12.1.5 Government Initiatives

      12.1.6 Regulations

      12.1.7 Regulatory Bodies

      12.1.8 Major Associations

      12.1.9 Taxes Levied

      12.1.10 Corporate Tax Structure

      12.1.11 Investments

      12.1.12 Major Companies

      12.2 Asia Pacific Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.3 Asia Pacific Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.4 Asia Pacific Veterinary Pharmaceuticals Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.5 Asia-Pacific Veterinary Pharmaceuticals Market: Country Analysis

      12.6 China Market

      12.7 Summary

      12.7.1 Market Overview

      12.7.2 Country Information

      12.7.3 Market Information

      12.7.4 Background Information

      12.7.5 Government Initiatives

      12.7.6 Regulations

      12.7.7 Regulatory Bodies

      12.7.8 Major Associations

      12.7.9 Taxes Levied

      12.7.10 Corporate Tax Structure

      12.7.11 Investments

      12.7.12 Major Companies

      12.8 China Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.9 China Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.10 China Veterinary Pharmaceuticals Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.11 India Market

      12.12 India Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.13 India Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.14 India Veterinary Pharmaceuticals Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.15 Japan Market

      12.16 Japan Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.17 Japan Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.18 Japan Veterinary Pharmaceuticals Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.19 Australia Market

      12.20 Australia Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.21 Australia Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.22 Australia Veterinary Pharmaceuticals Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.23 Indonesia Market

      12.24 Indonesia Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.25 Indonesia Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.26 Indonesia Veterinary Pharmaceuticals Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.27 South Korea Market

      12.28 South Korea Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.29 South Korea Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.30 South Korea Veterinary Pharmaceuticals Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13 Western Europe Market

      13.1 Summary

      13.1.1 Market Overview

      13.1.2 Region Information

      13.1.3 Market Information

      13.1.4 Background Information

      13.1.5 Government Initiatives

      13.1.6 Regulations

      13.1.7 Regulatory Bodies

      13.1.8 Major Associations

      13.1.9 Taxes Levied

      13.1.10 Corporate Tax Structure

      13.1.11 Investments

      13.1.12 Major Companies

      13.2 Western Europe Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.3 Western Europe Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.4 Western Europe Veterinary Pharmaceuticals Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.5 Western Europe Veterinary Pharmaceuticals Market: Country Analysis

      13.6 UK Market

      13.7 UK Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.8 UK Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.9 UK Veterinary Pharmaceuticals Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.10 Germany Market

      13.11 Germany Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.12 Germany Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.13 Germany Veterinary Pharmaceuticals Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.14 France Market

      13.15 France Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.16 France Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.17 France Veterinary Pharmaceuticals Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.18 Italy Market

      13.19 Italy Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.20 Italy Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.21 Italy Veterinary Pharmaceuticals Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.22 Spain Market

      13.23 Spain Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.24 Spain Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.25 Spain Veterinary Pharmaceuticals Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      14 Eastern Europe Market

      14.1 Summary

      14.1.1 Market Overview

      14.1.2 Region Information

      14.1.3 Market Information

      14.1.4 Background Information

      14.1.5 Government Initiatives

      14.1.6 Regulations

      14.1.7 Regulatory Bodies

      14.1.8 Major Associations

      14.1.9 Taxes Levied

      14.1.10 Corporate Tax Structure

      14.1.11 Investments

      14.1.12 Major Companies

      14.2 Eastern Europe Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      14.3 Eastern Europe Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      14.4 Eastern Europe Veterinary Pharmaceuticals Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      14.5 Eastern Europe Veterinary Pharmaceuticals Market: Country Analysis

      14.6 Russia Market

      14.7 Russia Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      14.8 Russia Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      14.9 Russia Veterinary Pharmaceuticals Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      15 North America Market

      15.1 Summary

      15.1.1 Market Overview

      15.1.2 Region Information

      15.1.3 Market Information

      15.1.4 Background Information

      15.1.5 Government Initiatives

      15.1.6 Regulations

      15.1.7 Regulatory Bodies

      15.1.8 Major Associations

      15.1.9 Taxes Levied

      15.1.10 Corporate Tax Structure

      15.1.11 Investments

      15.1.12 Major Companies

      15.2 North America Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      15.3 North America Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      15.4 North America Veterinary Pharmaceuticals Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      15.5 North America Veterinary Pharmaceuticals Market: Country Analysis

      15.6 USA Market

      15.7 Summary

      15.7.1 Market Overview

      15.7.2 Country Information

      15.7.3 Market Information

      15.7.4 Background Information

      15.7.5 Government Initiatives

      15.7.6 Regulations

      15.7.7 Regulatory Bodies

      15.7.8 Major Associations

      15.7.9 Taxes Levied

      15.7.10 Corporate Tax Structure

      15.7.11 Investments

      15.7.12 Major Companies

      15.8 USA Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      15.9 USA Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      15.10 USA Veterinary Pharmaceuticals Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      15.11 Canada Market

      15.12 Summary

      15.12.1 Market Overview

      15.12.2 Country Information

      15.12.3 Market Information

      15.12.4 Background Information

      15.12.5 Government Initiatives

      15.12.6 Regulations

      15.12.7 Regulatory Bodies

      15.12.8 Major Associations

      15.12.9 Taxes Levied

      15.12.10 Corporate Tax Structure

      15.12.11 Investments

      15.12.12 Major Companies

      15.13 Canada Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      15.14 Canada Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      15.15 Canada Veterinary Pharmaceuticals Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      15.16 Ontario Market

      15.17 Ontario Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      15.18 Ontario Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      15.19 Ontario Veterinary Pharmaceuticals Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      16 South America Market

      16.1 Summary

      16.1.1 Market Overview 250

      16.1.2 Region Information

      16.1.3 Market Information

      16.1.4 Background Information

      16.1.5 Government Initiatives

      16.1.6 Regulations

      16.1.7 Regulatory Bodies

      16.1.8 Major Associations

      16.1.9 Taxes Levied

      16.1.10 Corporate Tax Structure

      16.1.11 Investments

      16.1.12 Major Companies

      16.2 South America Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      16.3 South America Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      16.4 South America Veterinary Pharmaceuticals Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      16.5 South America Veterinary Pharmaceuticals Market: Country Analysis

      16.6 Brazil Market

      16.7 Brazil Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      16.8 Brazil Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      16.9 Brazil Veterinary Pharmaceuticals Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      17 Middle East Market

      17.1 Summary

      17.1.1 Market Overview

      17.1.2 Region Information

      17.1.3 Market Information

      17.1.4 Background Information

      17.1.5 Government Initiatives

      17.1.6 Regulations

      17.1.7 Regulatory Bodies

      17.1.8 Major Associations

      17.1.9 Taxes Levied

      17.1.10 Corporate Tax Structure

      17.1.11 Investments

      17.1.12 Major Companies

      17.2 Middle East Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      17.3 Middle East Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      17.4 Middle East Veterinary Pharmaceuticals Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      18 Africa Market

      18.1 Summary

      18.1.1 Market Overview

      18.1.2 Region Information

      18.1.3 Market Information

      18.1.4 Background Information

      18.1.5 Government Initiatives

      18.1.6 Regulations

      18.1.7 Regulatory Bodies

      18.1.8 Major Associations

      18.1.9 Taxes Levied

      18.1.10 Corporate Tax Structure

      18.1.11 Investments

      18.1.12 Major Companies

      18.2 Africa Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      18.3 Africa Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      18.4 Africa Veterinary Pharmaceuticals Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      19 Competitive Landscape And Company Profiles

      19.1 Merck & Co., Inc.

      19.1.1 Company Overview

      19.1.2 Products And Services

      19.1.3 Business Strategy

      19.1.4 Financial Overview

      19.2 Boehringer Ingelheim International GmbH

      19.2.1 Company Overview

      19.2.2 Products And Services

      19.2.3 Business Strategy

      19.2.4 Financial Overview

      19.3 Elanco Animal Health Incorporated

      19.3.1 Company Overview

      19.3.2 Products And Services

      19.3.3 Business Strategy

      19.3.4 Financial Overview

      19.4 Zoetis Inc.

      19.4.1 Company Overview

      19.4.2 Products And Services

      19.4.3 Business Strategy

      19.4.4 Financial Overview

      19.5 Ceva Santé Animale

      19.5.1 Company Overview

      19.5.2 Products And Services

      19.5.3 Business Strategy

      19.5.4 Financial Overview

      20 Other Major And Innovative Companies

      20.1 Virbac SA

      20.1.1 Company Overview

      20.1.2 Products And Services

      20.2 Vetoquinol S.A.

      20.2.1 Company Overview

      20.2.2 Products And Services

      20.3 Dechra Pharmaceuticals PLC

      20.3.1 Company Overview

      20.3.2 Products And Services

      20.4 Evonik Industries AG

      20.4.1 Company Overview

      20.4.2 Products And Services

      20.5 Zydus Animal Health

      20.5.1 Company Overview

      20.5.2 Products And Services

      20.6 Eco Animal Health

      20.6.1 Company Overview

      20.6.2 Products And Services

      20.7 Animalcare Group

      20.7.1 Company Overview

      20.7.2 Products And Services

      20.8 Neogen Corp

      20.8.1 Company Overview

      20.8.2 Products And Services

      20.9 Phibro Animal Health

      20.9.1 Company Overview

      20.9.2 Products And Services

      20.10 Mobedco-Vet

      20.10.1 Company Overview

      20.10.2 Products And Services

      20.11 ImmuCell Corporation

      20.11.1 Company Overview

      20.11.2 Products And Services

      20.12 Ourofino Saúde Animal

      20.12.1 Company Overview

      20.12.2 Products And Services

      20.13 Hipra

      20.13.1 Company Overview

      20.13.2 Products And Services

      20.14 Biogenesis Bago

      20.14.1 Company Overview

      20.14.2 Products And Services

      20.15 Huvepharma

      20.15.1 Company Overview

      20.15.2 Products And Services

      21 Competitive Benchmarking

      22 Competitive Dashboard

      23 Key Mergers And Acquisitions

      23.1 Phibro Animal Health Corporation Acquired Zoetis’

      23.2 Merck Animal Health Acquired Elanco Animal Health's

      23.3 EQT Acquired Dechra Pharmaceuticals

      23.4 Wedgewood Pharmacy Merged With Blue Rabbit

      23.5 Sun Pharmaceutical Acquired A Majority Stake In Vivaldis Health and Foods

      23.6 Orion Corporation Acquired VMD NV

      23.7 Zendal Group Acquired Maymo

      23.8 Mitsui Acquired Sumitomo Pharma Animal Health

      23.9 Zoetis Acquired Jurox

      23.10 Vimian Group Acquired Heiland GmbH

      23.11 Dechra Acquired Med-Pharmex

      23.12 Bimeda Acquired Afrivet

      23.13 Dechra Pharmaceuticals Acquired Piedmont Animal Health

      23.14 Virbac Acquired Assets Of Elanco Animal Health Inc.

      23.15 Vetoquinol Acquired Australian Assets Of Elanco Animal Health Inc.

      24 Opportunities And Strategies

      24.1 Global Veterinary Pharmaceuticals Market In 2028 – Countries Offering Most New Opportunities

      24.2 Global Veterinary Pharmaceuticals Market In 2028 – Segments Offering Most New Opportunities

      24.3 Global Veterinary Pharmaceuticals Market In 2028 – Growth Strategies

      24.3.1 Market Trend Based Strategies

      24.3.2 Competitor Strategies

      25 Veterinary Pharmaceuticals Market, Conclusions And Recommendations

      25.1 Conclusions

      25.2 Recommendations

      25.2.1 Product

      25.2.2 Place

      25.2.3 Price

      25.2.4 Promotion

      25.2.5 People

      26 Appendix

      26.1 Geographies Covered

      26.2 Market Data Sources

      26.3 Research Methodology

      26.4 Currencies

      26.5 The Business Research Company

      26.6 Copyright and Disclaimer

    List Of Tables

      Table 1: Global Veterinary Pharmaceuticals Market, Historic, 2018 – 2023, $ Million
    • Table 2: Global Veterinary Pharmaceuticals Market, Forecast, 2023 – 2028, 2033F, $ Million
    • Table 3: Global Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 4: Global Veterinary Pharmaceuticals Market, Segmentation By Type Of Animal, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 5: Global Veterinary Pharmaceuticals Market, Segmentation By Type Of Vaccine, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 6: Global Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 7: Global Veterinary Pharmaceuticals Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 8: Global Veterinary Pharmaceuticals Market, By Region, Historic and Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 9: Global Veterinary Pharmaceuticals Market, By Country, Historic and Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 10: Asia-Pacific GDP Per Capita, By Country, 2018-2023, $
    • Table 11: Asia Pacific Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 12: Asia Pacific Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 13: Asia Pacific Veterinary Pharmaceuticals Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 14: China GDP Per Capita, 2018-2023, $
    • Table 15: China Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 16: China Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 17: China Veterinary Pharmaceuticals Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 18: India Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 19: India Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 20: India Veterinary Pharmaceuticals Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 21: Japan Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 22: Japan Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 23: Japan Veterinary Pharmaceuticals Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 24: Australia Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 25: Australia Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 26: Australia Veterinary Pharmaceuticals Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 27: Indonesia Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 28: Indonesia Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 29: Indonesia Veterinary Pharmaceuticals Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 30: South Korea Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 31: South Korea Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 32: South Korea Veterinary Pharmaceuticals Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 33: Western Europe GDP Per Capita, By Country, 2018-2023, $
    • Table 34: Western Europe Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 35: Western Europe Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 36: Western Europe Veterinary Pharmaceuticals Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 37: UK Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 38: UK Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 39: UK Veterinary Pharmaceuticals Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 40: Germany Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 41: Germany Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 42: Germany Veterinary Pharmaceuticals Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 43: France Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 44: France Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 45: France Veterinary Pharmaceuticals Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 46: Italy Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 47: Italy Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 48: Italy Veterinary Pharmaceuticals Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 49: Spain Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 50: Spain Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 51: Spain Veterinary Pharmaceuticals Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 52: Eastern Europe GDP Per Capita, By Country, 2018-2023, $
    • Table 53: Eastern Europe Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 54: Eastern Europe Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 55: Eastern Europe Veterinary Pharmaceuticals Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 56: Russia Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 57: Russia Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 58: Russia Veterinary Pharmaceuticals Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 59: North America GDP Per Capita, By Country, 2018-2023, $
    • Table 60: North America Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 61: North America Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 62: North America Veterinary Pharmaceuticals Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 63: USA GDP Per Capita, 2018-2023, $
    • Table 64: USA Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 65: USA Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 66: USA Veterinary Pharmaceuticals Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 67: Canada GDP Per Capita, 2018-2023, $
    • Table 68: Canada Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 69: Canada Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 70: Canada Veterinary Pharmaceuticals Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 71: Ontario Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 72: Ontario Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 73: Ontario Veterinary Pharmaceuticals Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 74: South America GDP Per Capita, By Country, 2018-2023, $
    • Table 75: South America Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 76: South America Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 77: South America Veterinary Pharmaceuticals Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 78: Brazil Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 79: Brazil Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 80: Brazil Veterinary Pharmaceuticals Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 81: Middle East GDP Per Capita, By Country, 2018-2023, $
    • Table 82: Middle East Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 83: Middle East Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 84: Middle East Veterinary Pharmaceuticals Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 85: Africa GDP Per Capita, By Country, 2018-2023, $
    • Table 86: Africa Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 87: Africa Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 88: Africa Veterinary Pharmaceuticals Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 89: Global Veterinary Pharmaceuticals Market, Key Competitor Estimated Market Shares, 2022, Percentage (%)
    • Table 90: Merck & Co – Financial Overview, 2018 – 2022, $ Billion
    • Table 91: Boehringer Ingelheim International – Financial Overview, 2018 – 2022, $ Billion
    • Table 92: Elanco Animal Health – Financial Overview, 2018 – 2022, $ Billion
    • Table 93: Zoetis Inc – Financial Overview, 2018 – 2022, $ Billion
    • Table 94: Ceva Santé Animale – Financial Overview, 2022, $Million
    • Table 95: Veterinary Pharmaceuticals Market, Competitive Benchmarking (In USD Millions)
    • Table 96: Veterinary Pharmaceuticals Market, Competitive Dashboard
    • Table 97: Global Veterinary Pharmaceuticals Market Size Gain ($ Million), 2023 – 2028, By Country
    • Table 98: Global Veterinary Pharmaceuticals Market Size Gain ($ Million), Segmentation By Type, 2023 – 2028
    • Table 99: Global Veterinary Pharmaceuticals Market Size Gain ($ Million), Segmentation By Type Of Animal, 2023 – 2028
    • Table 100: Global Veterinary Pharmaceuticals Market Size Gain ($ Million), Segmentation By Type Of Vaccine, 2023 – 2028
    • Table 101: Global Veterinary Pharmaceuticals Market Size Gain ($ Million), Segmentation By Route Of Administration, 2023 – 2028
    • Table 102: Global Veterinary Pharmaceuticals Market Size Gain ($ Million), Segmentation By End-User, 2023 – 2028
    • Table 103: Veterinary Pharmaceuticals Market Data Sources

    List Of Figures

      Figure 1: Global Veterinary Pharmaceuticals Market Segmentation By Type
    • Figure 2: Global Veterinary Pharmaceuticals Market Segmentation By Type Of Animal
    • Figure 3: Global Veterinary Pharmaceuticals Market Segmentation By Type Of Vaccine
    • Figure 4: Global Veterinary Pharmaceuticals Market Segmentation By Route Of Administration
    • Figure 5: Global Veterinary Pharmaceuticals Market Segmentation By End-User
    • Figure 6: Global Veterinary Pharmaceuticals Market, Historic, 2018 – 2023, $ Million
    • Figure 7: Global Veterinary Pharmaceuticals Market, Forecast, 2023 – 2028, 2033F, $ Million
    • Figure 8: Global Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 9: Global Veterinary Pharmaceuticals Market, Segmentation By Type Of Animal, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 10: Global Veterinary Pharmaceuticals Market, Segmentation By Type Of Vaccine, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 11: Global Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 12: Global Veterinary Pharmaceuticals Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 13: Global Veterinary Pharmaceuticals Market, By Region, Historic and Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 14: Global Veterinary Pharmaceuticals Market, By Country, Historic and Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 15: Asia Pacific Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 16: Asia Pacific Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 17: Asia Pacific Veterinary Pharmaceuticals Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 18: China Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 19: China Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 20: China Veterinary Pharmaceuticals Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 21: India Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 22: India Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 23: India Veterinary Pharmaceuticals Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 24: Japan Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 25: Japan Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 26: Japan Veterinary Pharmaceuticals Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 27: Australia Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 28: Australia Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 29: Australia Veterinary Pharmaceuticals Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 30: Indonesia Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 31: Indonesia Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 32: Indonesia Veterinary Pharmaceuticals Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 33: South Korea Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 34: South Korea Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 35: South Korea Veterinary Pharmaceuticals Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 36: Western Europe Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 37: Western Europe Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 38: Western Europe Veterinary Pharmaceuticals Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 39: UK Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 40: UK Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 41: UK Veterinary Pharmaceuticals Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 42: Germany Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 43: Germany Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 44: Germany Veterinary Pharmaceuticals Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 45: France Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 46: France Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 47: France Veterinary Pharmaceuticals Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 48: Italy Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 49: Italy Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 50: Italy Veterinary Pharmaceuticals Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 51: Spain Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 52: Spain Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 53: Spain Veterinary Pharmaceuticals Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 54: Eastern Europe Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 55: Eastern Europe Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 56: Eastern Europe Veterinary Pharmaceuticals Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 57: Russia Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 58: Russia Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 59: Russia Veterinary Pharmaceuticals Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 60: North America Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 61: North America Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 62: North America Veterinary Pharmaceuticals Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 63: USA Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 64: USA Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 65: USA Veterinary Pharmaceuticals Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 66: Canada Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 67: Canada Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 68: Canada Veterinary Pharmaceuticals Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 69: Ontario Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 70: Ontario Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 71: Ontario Veterinary Pharmaceuticals Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 72: South America Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 73: South America Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 74: South America Veterinary Pharmaceuticals Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 75: Brazil Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 76: Brazil Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 77: Brazil Veterinary Pharmaceuticals Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 78: Middle East Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 79: Middle East Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 80: Middle East Veterinary Pharmaceuticals Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 81: Africa Veterinary Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 82: Africa Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 83: Africa Veterinary Pharmaceuticals Market, Segmentation By End-User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 84: Global Veterinary Pharmaceuticals Market, Key Competitor Estimated Market Shares, 2022, Percentage (%)
    • Figure 85: Merck & Co – Financial Overview, 2018 – 2022, $ Billion
    • Figure 86: Boehringer Ingelheim International – Financial Overview, 2018 – 2022, $ Billion
    • Figure 87: Elanco Animal Health – Financial Overview, 2018 – 2022, $ Billion
    • Figure 88: Zoetis Inc – Financial Overview, 2018 – 2022, $ Billion
    • Figure 89: Geographic Regions Covered
    View Report
    View Report
    View Report
    View Report
    View Report
    View Report

    Frequently Asked Questions

    What is the definition of the veterinary pharmaceuticals market?

    The veterinary pharmaceuticals market consists of sales of veterinary pharmaceuticals and related services. This industry includes establishments that produce veterinary medicines which are used for pet animals and farm animals (includes vaccines, antibiotics and parasiticides). request a sample here

    How will the veterinary pharmaceuticals market drivers and restraints affect veterinary pharmaceuticals market dynamics? What forces will shape the veterinary pharmaceuticals industry going forward?

    The veterinary pharmaceuticals market growth is aided by Increase in the prevalence rate of diseases among animals. However, some veterinary pharmaceuticals market restraints include lack of awareness about animal healthcare request a sample here

    What is the forecast market size of the veterinary pharmaceuticals market?

    The veterinary pharmaceuticals market forecast is expected to reach $19.7 billion in 2023 at a compound annual growth rate of 7.5%. request a sample here

    How is the veterinary pharmaceuticals market segmented?

    The global veterinary pharmaceuticals market is segmented -
    1) By Type: Veterinary Vaccines, Veterinary Antibiotics, Veterinary Parasiticides, Others.
    2) By End User: Veterinary Hospitals, Veterinary Clinics, Pharmacies and Drug stores.
    3) By Route of Administration: Oral, Others (Parental, Topical).
    4) By Animal Type: Companion Animals, Livestock Animals.
    5) By Vaccines: Inactivated vaccines, Attenuated vaccines, Recombinant vaccines.
    request a sample here

    Which region has largest share, and what is the market size and growth by geography according to the veterinary pharmaceuticals global market report?

    For more detail on this, request a sample here.

    Who are the key players of the global veterinary pharmaceuticals market?

    Top competitors in the veterinary pharmaceuticals market are Merck & Co. Inc, Zoetis Inc., Eli Lilly and Company, Bayer AG, Boehringer Ingelheim GmbH, Perrigo Company plc, Virbac SA, Dechra Pharmaceuticals plc, Ceva Sante Animale, Aratana Therapeutics, In request a sample here.

    What are the key trends in the global veterinary pharmaceuticals market?

    Major trends influencing the veterinary pharmaceuticals market include rise in generic drugs for animal care request a sample here.

    What are the major opportunities in the veterinary pharmaceuticals market and the approaches companies can take to take advantage of them?

    For detail on the future and current opportunities in the global veterinary pharmaceuticals market, request a sample here.

    How does the veterinary pharmaceuticals market relate to the overall economy and other similar markets?